Furoxanobenzofuroxan, a selective monoamine oxidase inhibitor.
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001667:Binding, Competitive; D001921:Brain / Q000201:enzymology; D002250:Carbon Radioisotopes; D003059:Cocos; D003497:Cyclic N-Oxides / Q000494:pharmacology; D003956:Dialysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006168:Guinea Pigs; D006213:Hallucinogens / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D008099:Liver / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000201:enzymology; D009638:Norepinephrine / Q000378:metabolism; D009821:Oils / Q000494:pharmacology; D010069:Oxadiazoles / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology; D012702:Serotonin Antagonists; D013050:Spectrometry, Fluorescence; D013997:Time Factors; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines / Q000378:metabolism
D000470:Alkaloids; D002250:Carbon Radioisotopes; D003497:Cyclic N-Oxides; D006213:Hallucinogens; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D009821:Oils; D010069:Oxadiazoles; D011725:Pyridines; D012702:Serotonin Antagonists; D014363:Tryptamines; D014191:Tranylcypromine; D009638:Norepinephrine